Search

Anthony C Arvanites

from Forest, VA
Age ~53
Get Report
Also known as:
Anthony D Arvanites, Anthony L Arvanites
Related to:
Steven A Arvanites, 95Brenda J Arvanites, 78
Connected to:
Artemis T Arvanitis, 38Chris S Arvanitis, 98Katerina N Arvanitakis, 42Konstantinos Arvanitis, 46Krista Arvanitis, 58Nektarios J Arvanitis, 46Spiros J Arvanitis, 103Steve Arvanitis, 64Tracy M Arvanitis, 62Valeriu Arvat, 71

Anthony Arvanites Phones & Addresses

  • Forest, VA
  • 15 Hicks Ave, Medford, MA 02155 (508) 951-1046
  • Erie, CO
  • 329 Cedar St, New Bedford, MA 02740 (508) 994-0360
  • 27 Willow St, New Bedford, MA 02740
  • Carmel, IN
  • North Dighton, MA
  • Houston, TX
  • Bellingham, WA
  • 15 Hicks Ave, Medford, MA 02155

Work

Position: Clerical/White Collar

Education

Degree: High school graduate or higher

Resumes

Resumes

Anthony Arvanites Photo 1

Associate Director It And Informatics

View page
Location:
Medford, MA
Industry:
Biotechnology
Work:
Fulcrum Therapeutics
Associate Director It and Informatics
Sanofi Nov 2014 - Jan 2017
Global Solution Leader Informatics
Harvard University Sep 2007 - Nov 2014
Manager of Cheminformatics For Screening
Cambria Biosciences Feb 2005 - Feb 2012
Cheminformatics Scientist and It Consultant
Inforsense Nov 2003 - Sep 2007
Applications Field Scientist and Consultant
Education:
Harvard University 2011 - 2014
Masters, Sustainability Harvard University 2008 - 2011
Masters, Management, Finance University of Massachusetts Dartmouth 1997 - 1998
Masters, Chemistry University of Massachusetts Dartmouth 1992 - 1997
Bachelors, Physics, Chemistry
Skills:
Drug Discovery
Cheminformatics
Computational Chemistry
High Throughput Screening
Life Sciences
Biochemistry
Drug Design
Chemistry
Bioinformatics
Pharmaceutical Industry
Organic Chemistry
Molecular Dynamics
Molecular Biology
Biotechnology
Qsar
Molecular Modeling
Cell
Lifesciences
Docking
Medicinal Chemistry
Cell Biology
Databases
Cell Culture
Informatics
Clinical Data Management
It Management
It Infrastructure Management
Data Modeling
Data Analysis
Data Management
Assay Development
Compound Management
Data Integration
Electronic Data Capture
Image Analysis
Computer Aided Design
Anthony Arvanites Photo 2

Anthony Arvanites

View page

Publications

Us Patents

Antibiotic Cycloalkyltetrahydroquinoline Derivatives

View page
US Patent:
20060287351, Dec 21, 2006
Filed:
Aug 11, 2004
Appl. No.:
10/568252
Inventors:
Richard Labaudiniere - Sherborn MA, US
Yibin Xiang - Acton MA, US
Ravi Jalluri - Avondale PA, US
Anthony Arvanites - New Bedford MA, US
International Classification:
A61K 31/473
US Classification:
514290000
Abstract:
p-00010000

Antibacterial Fab I Inhibitors

View page
US Patent:
20070027190, Feb 1, 2007
Filed:
Jan 16, 2004
Appl. No.:
10/542351
Inventors:
Donald Moir - Lexington MA, US
Yibin Xiang - Acton MA, US
Anthony Arvanites - New Bedford MA, US
Syed Ali - North Andover MA, US
Bolin Geng - Andover MA, US
Mark Ashwell - Carlisle MA, US
Hernan Orgueira - Cambridge MA, US
Alan Kaplan - Kings Park NY, US
International Classification:
A61K 31/4439
A61K 31/4436
A61K 31/4412
US Classification:
514341000, 514342000, 514344000
Abstract:
Disclosed herein are antibacterial compounds that inhibit fabl, a NADH-dependent enoyl [acyl carrier protein] reductase enzyme in the fatty acid biosynthesis pathway. The compounds are represented by structural formulas Ia and Ib: R1 and R2 are independently monocyclic aryl or heteroaryl groups, wherein the groups represented by R1 and R2 are optionally substituted with one or more acyclic substituents; R3 is —H or an optionally substituted C1-C8 aliphatic, C3-C8 cycloaliphatic, aryl, or heteroaryl group. X1 is a bond or a C1-C3 alkylene chain that is optionally substituted with a C1-C4 alkyl or an acidic group. X2 is an aryl, heteroaryl or C3-C8 cycloaliphatic ring, wherein the group represented by X2 is optionally substituted with triazole, tetrazole, and/or one or more acyclic substituents.

Treatment Of Amyotrophic Lateral Sclerosis

View page
US Patent:
20110237907, Sep 29, 2011
Filed:
Nov 20, 2009
Appl. No.:
13/129854
Inventors:
Donald R. Kirsch - Bedford MA, US
Radhia Benmohamed - Tewksbury MA, US
Anthony C. Arvanites - Medford MA, US
Richard I. Morimoto - Evanston IL, US
Tian Chen - Evanston IL, US
Richard B. Silverman - Northbrook IL, US
Assignee:
CAMBRIA PHARMACEUTICALS, INC. - Cambridge MA
NORTHWESTERN UNIVERSITY - Evanston IL
International Classification:
A61B 5/00
US Classification:
600301
Abstract:
The present invention relates to the identification of compounds and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided compounds.

Pyrimidine-2,4,6-Triones For Use In The Treatment Of Amyotrophic Lateral Sclerosis

View page
US Patent:
20120046309, Feb 23, 2012
Filed:
May 5, 2010
Appl. No.:
13/318429
Inventors:
Donald R. Kirsch - Bedford MA, US
Radhia Benmohamed - Tewksbury MA, US
Anthony C. Arvanites - Medford MA, US
Richard I. Morimoto - Evanston IL, US
Richard B. Silverman - Northbrook IL, US
Guoyao Xia - Chicago IL, US
Assignee:
NORTHWESTERN UNIVERSITY - Evanston IL
CAMBRIA PHARMACEUTICALS, INC. - Cambridge MA
International Classification:
A61K 31/515
C12N 5/02
C07D 403/06
A61P 25/00
C07D 239/62
C07D 409/14
US Classification:
514270, 544299, 544300, 544304, 544307, 544302, 544303, 544306, 435375
Abstract:
The present invention relates to the identification of inventive pyrimidine-2,4,6-triones (PYT compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the inventive PYT compounds.

Antibiotic Tetrahydro-Beta-Carboline Derivatives

View page
US Patent:
20060273819, Dec 7, 2006
Filed:
Apr 29, 2004
Appl. No.:
10/554756
Inventors:
Timothy Opperman - Arlington MA, US
Anthony Arvanites - Bedford MA, US
Julia Pinto - Beverly MA, US
Yibin Xiang - Acton MA, US
Syed Ali - North Andover MA, US
Bolin Geng - Andover MA, US
Mark Ashwell - Carlisle MA, US
Alan Kaplan - Kings Park NY, US
International Classification:
H03K 19/007
US Classification:
326014000
Abstract:
Disclosed are tetrahydro-β-carboline derivatives such as structural formula I, pharmaceutical compositions comprising them and methods of treating bacterial infections. The disclosed compounds are inhibitors of PPAT (phosphopantetheine adenyl transferase), and are useful in the treatment and prevention of diseases caused by bacteria, particularly bacteria dependent on PPAT, for example, species such and the like. Description of the variables in structural formula I are provided herein.

Cyclohexane-1,3-Diones For Use In The Treatment Of Amyotrophic Lateral Sclerosis

View page
US Patent:
20160039740, Feb 11, 2016
Filed:
Oct 20, 2015
Appl. No.:
14/887550
Inventors:
Donald R. Kirsch - Bedford MA, US
Radhia Benmohamed - Tewksbury MA, US
Anthony C. Arvanites - Medford MA, US
Richard J. Morimoto - Evanston IL, US
Wei Zhang - Evanston IL, US
Richard B. Silverman - Winnetka IL, US
International Classification:
C07C 69/75
C07C 49/577
C07C 49/567
Abstract:
The present invention relates to the identification of provided cyclohexane-1,3-diones (CHD compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided CHD compounds.

Pyrimidine-2,4,6-Triones For Use In The Treatment Of Amyotrophic Lateral Sclerosis

View page
US Patent:
20150203456, Jul 23, 2015
Filed:
Oct 4, 2013
Appl. No.:
14/046333
Inventors:
- Evanston IL, US
Radhia Benmohamed - Tewksbury MA, US
Anthony C. Arvanites - Medford MA, US
Richard I. Morimoto - Evanston IL, US
Richard B. Silverman - Northbrook IL, US
Guoyao Xia - Chicago IL, US
International Classification:
C07D 239/62
C07D 403/06
Abstract:
The present invention relates to the identification of inventive pyrimidine-2,4,6-triones (PYT compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the inventive PYT compounds.

Cyclohexane-1,3-Diones For Use In The Treatment Of Amyotrophic Lateral Sclerosis

View page
US Patent:
20140371313, Dec 18, 2014
Filed:
May 12, 2014
Appl. No.:
14/275167
Inventors:
- Evanston IL, US
- Cambridge MA, US
Anthony C. Arvanites - Medford MA, US
Richard I. Morimoto - Evanston IL, US
Wei Zhang - Evanston IL, US
Richard B. Silverman - Winnetka IL, US
International Classification:
C07C 69/75
C07C 49/577
C07C 49/563
US Classification:
514552, 514683, 560129, 568329
Abstract:
The present invention relates to the identification of provided cyclohexane-1,3-diones (CHD compounds) and pharmaceutical compositions thereof for treating subjects with amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The invention also provides methods of preparing the provided CHD compounds.
Control profile
Anthony C Arvanites from Forest, VA, age ~53 Get Report